This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
In a bid to continue bolstering its portfolio of cell-based drug-discovery tools, PerkinElmer said a couple of weeks ago that it would acquire Euroscreen Products, a subsidiary of Belgian drug-discovery operation Euroscreen, for an undisclosed cash sum.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.